????英國藥業(yè)巨頭葛蘭素史克（GlaxoSmithKline）正在接受英國反嚴(yán)重欺詐辦公室（Serious Fraud Office，SFO）對其商業(yè)行為的調(diào)查。

????這家公司自稱堅持“最高的道德標(biāo)準(zhǔn)”，并將“全力配合”政府調(diào)查。反嚴(yán)重欺詐辦公室在一份聲明中寫道：“反嚴(yán)重欺詐辦公室主任已經(jīng)開始對葛蘭素史克及其子公司的商業(yè)行為展開刑事調(diào)查?！钡@份聲明沒有詳細(xì)說明這家公司非法活動的性質(zhì)。

????本月早些時候，中國執(zhí)法部門指控葛蘭素史克賄賂醫(yī)院和政府官員。當(dāng)時，中國官方指控葛蘭素史克前中國區(qū)負(fù)責(zé)人馬克銳在中國建立了“龐大的賄賂網(wǎng)絡(luò)”。

????針對上述指控，葛蘭素史克在聲明中回應(yīng)稱：“我們非常認(rèn)真地對待中方提出的指控。我們對這些指控深表關(guān)切，這種行為違反了葛蘭素史克的價值。我們將繼續(xù)全力配合相關(guān)部門對該事件進(jìn)行調(diào)查。”

????BBC4月份報道稱，在波蘭，11名醫(yī)生和這家制藥公司的一名區(qū)域經(jīng)理因?yàn)?010年至2012年期間的腐敗行為而遭到了指控。

????據(jù)BBC報道，如果最近的指控屬實(shí)，那么，這家公司可能已經(jīng)違反了英國《反賄賂法》（UK Bribery Act）和美國《反海外腐敗法》（US Foreign Corrupt Practices Act）。

????目前尚無其他詳細(xì)信息。葛蘭素史克發(fā)言人也拒絕就此發(fā)表評論。（財富中文網(wǎng)）

????譯者：劉進(jìn)龍/汪皓

????GlaxoSmithKline (GSK), the British pharmaceutical giant, is under investigation by the UK's Serious Fraud Office (SFO) over its commercial practices.

????According to the company, it intends to uphold the "highest ethical standards" and will "cooperate fully" with the government inquiry. In a statement, the SFO wrote, "The Director of the SFO has opened a criminal investigation into the commercial practices of GlaxoSmithKline plc and its subsidiaries." It did not elaborate any further about the nature of any illegal activity by the company.

????Earlier this month, Chinese law enforcement accused GlaxoSmithKline of bribing hospital and government officials. At that time, Chinese authorities said GlaxoSmithKline's former China chief Mark Reilly was responsible for starting a "massive bribery network" in the country.

????In response to those accusations, GlaxoSmithKline said in a statement: "We take the allegations that have been raised very seriously. They are deeply concerning to us and contrary to the values of GlaxoSmithKline. We will continue to fully co-operate with the authorities in this matter."

????In Poland, meanwhile, 11 doctors and a regional manager for the pharmaceutical company were charged with corruption from 2010 to 2012, according to the BBC in April.

????If the latest allegations prove true, the company may have violated the UK Bribery Act and the US Foreign Corrupt Practices Act, according to the BBC.

????No other details were immediately available. A spokeswoman for GlaxoSmithKline declined to comment.